127 related articles for article (PubMed ID: 12871559)
1. Autoimmune disease antigen U1 snRNP neutralizes heparin.
Scully MF; Gebska MA
J Thromb Haemost; 2003 Jan; 1(1):189-90. PubMed ID: 12871559
[No Abstract] [Full Text] [Related]
2. Detection and epitope analysis of autoantigen-reactive T cells to the U1-small nuclear ribonucleoprotein A protein in autoimmune disease patients.
Okubo M; Yamamoto K; Kato T; Matsuura N; Nishimaki T; Kasukawa R; Ito K; Mizushima Y; Nishioka K
J Immunol; 1993 Jul; 151(2):1108-15. PubMed ID: 7687615
[TBL] [Abstract][Full Text] [Related]
3. The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases.
Kattah NH; Kattah MG; Utz PJ
Immunol Rev; 2010 Jan; 233(1):126-45. PubMed ID: 20192997
[TBL] [Abstract][Full Text] [Related]
4. Human anti-nuclear ribonucleoprotein antigen autoimmune sera contain a novel subset of autoantibodies that stabilizes the molecular interaction of U1RNP-C protein with the Sm core proteins.
Satoh M; Richards HB; Hamilton KJ; Reeves WH
J Immunol; 1997 May; 158(10):5017-25. PubMed ID: 9144522
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic modifications affect the autoreactivity of the U1 snRNP autoantigen.
Hof D; Raats JM; Pruijn GJ
Autoimmun Rev; 2005 Jul; 4(6):380-8. PubMed ID: 16081029
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and pharmacologic studies on the protamine interactions with heparin, its fractions and fragments.
Racanelli A; Fareed J; Walenga JM; Coyne E
Semin Thromb Hemost; 1985 Apr; 11(2):176-89. PubMed ID: 4035365
[No Abstract] [Full Text] [Related]
7. The U1 snRNP complex: an autoantigen in connective tissue diseases. An update.
Klein Gunnewiek JM; van de Putte LB; van Venrooij WJ
Clin Exp Rheumatol; 1997; 15(5):549-60. PubMed ID: 9307865
[TBL] [Abstract][Full Text] [Related]
8. Characterization of recombinant human autoantibody fragments directed toward the autoantigenic U1-70K protein.
Degen WG; Pieffers M; Welin-Henriksson E; van den Hoogen FH; van Venrooij WJ; Raats JM
Eur J Immunol; 2000 Oct; 30(10):3029-38. PubMed ID: 11069087
[TBL] [Abstract][Full Text] [Related]
9. Influence of heparin, protamine and polybrene on the time integral of thrombin generation (endogenous thrombin potential).
Rotteveel RC; Roozendaal KJ; Weijers RN; Eijsman L
Haemostasis; 1996; 26(1):1-10. PubMed ID: 8698272
[TBL] [Abstract][Full Text] [Related]
10. Human parvovirus B19 nonstructural protein NS1 enhanced the expression of cleavage of 70 kDa U1-snRNP autoantigen.
Tzang BS; Chen DY; Tsai CC; Chiang SY; Lin TM; Hsu TC
J Biomed Sci; 2010 May; 17(1):40. PubMed ID: 20500824
[TBL] [Abstract][Full Text] [Related]
11. In-vitro and ex-vivo neutralizing effect of protamine sulphate on the anticoagulant activity of a new low molecular mass heparin.
Falkon L; Garí M; Gich I; Fontcuberta J
Thromb Res; 1998 Jan; 89(2):79-83. PubMed ID: 9630311
[No Abstract] [Full Text] [Related]
12. The fate of the U1 snRNP autoantigen during apoptosis: implications for systemic autoimmunity.
Malmegrim KC; Pruijn GJ; van Venrooij WJ
Isr Med Assoc J; 2002 Sep; 4(9):706-12. PubMed ID: 12440236
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of low molecular weight heparin by protamine chloride in vivo.
Harenberg J; Gnasso A; de Vries JX; Zimmermann R; Augustin J
Thromb Res; 1985 Apr; 38(1):11-20. PubMed ID: 4002198
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis of TCRalpha and beta chains from human T-Cell clones specific for small nuclear ribonucleoprotein polypeptides Sm-D, Sm-B and U1-70 kDa: TCR complementarity determining region 3 usage appears highly conserved.
Talken BL; Bailey CW; Reardon SL; Caldwell CW; Hoffman RW
Scand J Immunol; 2001; 54(1-2):204-10. PubMed ID: 11439168
[TBL] [Abstract][Full Text] [Related]
15. In vivo neutralization of low-molecular weight heparin fraction CY 216 by protamine.
Doutremépuich C; Bonini F; Toulemonde F; Bertrand H; Bayrou B; Quilichini R
Semin Thromb Hemost; 1985 Jul; 11(3):318-22. PubMed ID: 4048954
[TBL] [Abstract][Full Text] [Related]
16. B cell epitope on the U1 snRNP-C autoantigen contains a sequence similar to that of the herpes simplex virus protein.
Misaki Y; Yamamoto K; Yanagi K; Miura H; Ichijo H; Kato T; Mato T; Welling-Wester S; Nishioka K; Ito K
Eur J Immunol; 1993 May; 23(5):1064-71. PubMed ID: 7682956
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies that stabilize U1snRNP are a significant component of human autoantibodies to snRNP and delay proteolysis of sm antigens in vitro.
Satoh M; Akaogi J; Kuroda Y; Nacionales DC; Yoshida H; Yamasaki Y; Reeves WH
J Rheumatol; 2004 Dec; 31(12):2382-9. PubMed ID: 15570638
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the effect of varying protamine-to-heparin ratio on coagulation in vitro.
Ho LTS; McVey MJ; Kuiper GJAJM; Gross PL; Karkouti K
Br J Anaesth; 2021 Oct; 127(4):e128-e130. PubMed ID: 34334192
[No Abstract] [Full Text] [Related]
19. [Neutralization of low molecular weight heparin Kabi 2165 by protamine chloride].
Harenberg J; Giese C; Knödler A; Zimmermann R; Schettler G
Klin Wochenschr; 1986 Nov; 64(22):1171-5. PubMed ID: 3807263
[TBL] [Abstract][Full Text] [Related]
20. T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice.
Monneaux F; Lozano JM; Patarroyo ME; Briand JP; Muller S
Eur J Immunol; 2003 Feb; 33(2):287-96. PubMed ID: 12548559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
